カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のカルメット-ゲラン桿菌ワクチン市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Bacillus Calmette Guerin Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19168）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19168
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：110
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のカルメット-ゲラン桿菌ワクチン市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

カルメット-ゲラン桿菌ワクチン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のカルメット-ゲラン桿菌ワクチンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

カルメット-ゲラン桿菌ワクチン市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・免疫型、治療型

用途別セグメントは次のように区分されます。
・病院、診療所、その他

世界のカルメット-ゲラン桿菌ワクチン市場の主要な市場プレーヤーは以下のとおりです。
・Merck、Sanofi Pasteur、Japan BCG Lab、China National Biotec、AJ Vaccines、Serum Institute of India、Intervax、GSBPL、Statens Serum Institute、Biomed Lublin、ANLIS Malbran、Fundação Ataulpho de Paiva、BB-NCIPD、Taj Pharmaceuticals、Bio Farma、Microgen、Torlakinstitut、Institut Pasteur de Tunis、IVAC

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、カルメット-ゲラン桿菌ワクチン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なカルメット-ゲラン桿菌ワクチンメーカーの企業概要、2019年～2022年までのカルメット-ゲラン桿菌ワクチンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なカルメット-ゲラン桿菌ワクチンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別カルメット-ゲラン桿菌ワクチンの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのカルメット-ゲラン桿菌ワクチンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのカルメット-ゲラン桿菌ワクチン市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびカルメット-ゲラン桿菌ワクチンの産業チェーンを掲載しています。
・第13、14、15章では、カルメット-ゲラン桿菌ワクチンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- カルメット-ゲラン桿菌ワクチンの概要
- 種類別分析（2017年vs2021年vs2028年）：免疫型、治療型
- 用途別分析（2017年vs2021年vs2028年）：病院、診療所、その他
- 世界のカルメット-ゲラン桿菌ワクチン市場規模・予測
- 世界のカルメット-ゲラン桿菌ワクチン生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Merck、Sanofi Pasteur、Japan BCG Lab、China National Biotec、AJ Vaccines、Serum Institute of India、Intervax、GSBPL、Statens Serum Institute、Biomed Lublin、ANLIS Malbran、Fundação Ataulpho de Paiva、BB-NCIPD、Taj Pharmaceuticals、Bio Farma、Microgen、Torlakinstitut、Institut Pasteur de Tunis、IVAC
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：免疫型、治療型
・用途別分析2017年-2028年：病院、診療所、その他
・カルメット-ゲラン桿菌ワクチンの北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・カルメット-ゲラン桿菌ワクチンのヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・カルメット-ゲラン桿菌ワクチンのアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・カルメット-ゲラン桿菌ワクチンの南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・カルメット-ゲラン桿菌ワクチンの中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Bacillus Calmette Guerin Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Bacillus Calmette Guerin Vaccine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Hospitals accounting for % of the Bacillus Calmette Guerin Vaccine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Immune Type segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Bacillus Calmette Guerin Vaccine include Merck, Sanofi Pasteur, Japan BCG Lab, China National Biotec, and AJ Vaccines, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Bacillus Calmette Guerin Vaccine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Immune Type
Therapy Type
Market segment by Application can be divided into
Hospitals
Clinics
Others
The key market players for global Bacillus Calmette Guerin Vaccine market are listed below:
Merck
Sanofi Pasteur
Japan BCG Lab
China National Biotec
AJ Vaccines
Serum Institute of India
Intervax
GSBPL
Statens Serum Institute
Biomed Lublin
ANLIS Malbran
Fundação Ataulpho de Paiva
BB-NCIPD
Taj Pharmaceuticals
Bio Farma
Microgen
Torlakinstitut
Institut Pasteur de Tunis
IVAC
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Bacillus Calmette Guerin Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Bacillus Calmette Guerin Vaccine, with price, sales, revenue and global market share of Bacillus Calmette Guerin Vaccine from 2019 to 2022.
Chapter 3, the Bacillus Calmette Guerin Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Bacillus Calmette Guerin Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Bacillus Calmette Guerin Vaccine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Bacillus Calmette Guerin Vaccine.
Chapter 13, 14, and 15, to describe Bacillus Calmette Guerin Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Bacillus Calmette Guerin Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Bacillus Calmette Guerin Vaccine Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Immune Type
1.2.3 Therapy Type
1.3 Market Analysis by Application
1.3.1 Overview: Global Bacillus Calmette Guerin Vaccine Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Bacillus Calmette Guerin Vaccine Market Size & Forecast
1.4.1 Global Bacillus Calmette Guerin Vaccine Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Bacillus Calmette Guerin Vaccine Sales in Volume (2017-2028)
1.4.3 Global Bacillus Calmette Guerin Vaccine Price (2017-2028)
1.5 Global Bacillus Calmette Guerin Vaccine Production Capacity Analysis
1.5.1 Global Bacillus Calmette Guerin Vaccine Total Production Capacity (2017-2028)
1.5.2 Global Bacillus Calmette Guerin Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Bacillus Calmette Guerin Vaccine Market Drivers
1.6.2 Bacillus Calmette Guerin Vaccine Market Restraints
1.6.3 Bacillus Calmette Guerin Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Bacillus Calmette Guerin Vaccine Product and Services
2.1.4 Merck Bacillus Calmette Guerin Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Sanofi Pasteur
2.2.1 Sanofi Pasteur Details
2.2.2 Sanofi Pasteur Major Business
2.2.3 Sanofi Pasteur Bacillus Calmette Guerin Vaccine Product and Services
2.2.4 Sanofi Pasteur Bacillus Calmette Guerin Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Japan BCG Lab
2.3.1 Japan BCG Lab Details
2.3.2 Japan BCG Lab Major Business
2.3.3 Japan BCG Lab Bacillus Calmette Guerin Vaccine Product and Services
2.3.4 Japan BCG Lab Bacillus Calmette Guerin Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 China National Biotec
2.4.1 China National Biotec Details
2.4.2 China National Biotec Major Business
2.4.3 China National Biotec Bacillus Calmette Guerin Vaccine Product and Services
2.4.4 China National Biotec Bacillus Calmette Guerin Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 AJ Vaccines
2.5.1 AJ Vaccines Details
2.5.2 AJ Vaccines Major Business
2.5.3 AJ Vaccines Bacillus Calmette Guerin Vaccine Product and Services
2.5.4 AJ Vaccines Bacillus Calmette Guerin Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Serum Institute of India
2.6.1 Serum Institute of India Details
2.6.2 Serum Institute of India Major Business
2.6.3 Serum Institute of India Bacillus Calmette Guerin Vaccine Product and Services
2.6.4 Serum Institute of India Bacillus Calmette Guerin Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Intervax
2.7.1 Intervax Details
2.7.2 Intervax Major Business
2.7.3 Intervax Bacillus Calmette Guerin Vaccine Product and Services
2.7.4 Intervax Bacillus Calmette Guerin Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 GSBPL
2.8.1 GSBPL Details
2.8.2 GSBPL Major Business
2.8.3 GSBPL Bacillus Calmette Guerin Vaccine Product and Services
2.8.4 GSBPL Bacillus Calmette Guerin Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Statens Serum Institute
2.9.1 Statens Serum Institute Details
2.9.2 Statens Serum Institute Major Business
2.9.3 Statens Serum Institute Bacillus Calmette Guerin Vaccine Product and Services
2.9.4 Statens Serum Institute Bacillus Calmette Guerin Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Biomed Lublin
2.10.1 Biomed Lublin Details
2.10.2 Biomed Lublin Major Business
2.10.3 Biomed Lublin Bacillus Calmette Guerin Vaccine Product and Services
2.10.4 Biomed Lublin Bacillus Calmette Guerin Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 ANLIS Malbran
2.11.1 ANLIS Malbran Details
2.11.2 ANLIS Malbran Major Business
2.11.3 ANLIS Malbran Bacillus Calmette Guerin Vaccine Product and Services
2.11.4 ANLIS Malbran Bacillus Calmette Guerin Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Fundação Ataulpho de Paiva
2.12.1 Fundação Ataulpho de Paiva Details
2.12.2 Fundação Ataulpho de Paiva Major Business
2.12.3 Fundação Ataulpho de Paiva Bacillus Calmette Guerin Vaccine Product and Services
2.12.4 Fundação Ataulpho de Paiva Bacillus Calmette Guerin Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 BB-NCIPD
2.13.1 BB-NCIPD Details
2.13.2 BB-NCIPD Major Business
2.13.3 BB-NCIPD Bacillus Calmette Guerin Vaccine Product and Services
2.13.4 BB-NCIPD Bacillus Calmette Guerin Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Taj Pharmaceuticals
2.14.1 Taj Pharmaceuticals Details
2.14.2 Taj Pharmaceuticals Major Business
2.14.3 Taj Pharmaceuticals Bacillus Calmette Guerin Vaccine Product and Services
2.14.4 Taj Pharmaceuticals Bacillus Calmette Guerin Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Bio Farma
2.15.1 Bio Farma Details
2.15.2 Bio Farma Major Business
2.15.3 Bio Farma Bacillus Calmette Guerin Vaccine Product and Services
2.15.4 Bio Farma Bacillus Calmette Guerin Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Microgen
2.16.1 Microgen Details
2.16.2 Microgen Major Business
2.16.3 Microgen Bacillus Calmette Guerin Vaccine Product and Services
2.16.4 Microgen Bacillus Calmette Guerin Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 Torlakinstitut
2.17.1 Torlakinstitut Details
2.17.2 Torlakinstitut Major Business
2.17.3 Torlakinstitut Bacillus Calmette Guerin Vaccine Product and Services
2.17.4 Torlakinstitut Bacillus Calmette Guerin Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18 Institut Pasteur de Tunis
2.18.1 Institut Pasteur de Tunis Details
2.18.2 Institut Pasteur de Tunis Major Business
2.18.3 Institut Pasteur de Tunis Bacillus Calmette Guerin Vaccine Product and Services
2.18.4 Institut Pasteur de Tunis Bacillus Calmette Guerin Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19 IVAC
2.19.1 IVAC Details
2.19.2 IVAC Major Business
2.19.3 IVAC Bacillus Calmette Guerin Vaccine Product and Services
2.19.4 IVAC Bacillus Calmette Guerin Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Bacillus Calmette Guerin Vaccine Breakdown Data by Manufacturer
3.1 Global Bacillus Calmette Guerin Vaccine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Bacillus Calmette Guerin Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Bacillus Calmette Guerin Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 Bacillus Calmette Guerin Vaccine Manufacturer Market Share in 2021
3.4.2 Top 6 Bacillus Calmette Guerin Vaccine Manufacturer Market Share in 2021
3.5 Global Bacillus Calmette Guerin Vaccine Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Bacillus Calmette Guerin Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Bacillus Calmette Guerin Vaccine Market Size by Region
4.1.1 Global Bacillus Calmette Guerin Vaccine Sales in Volume by Region (2017-2028)
4.1.2 Global Bacillus Calmette Guerin Vaccine Revenue by Region (2017-2028)
4.2 North America Bacillus Calmette Guerin Vaccine Revenue (2017-2028)
4.3 Europe Bacillus Calmette Guerin Vaccine Revenue (2017-2028)
4.4 Asia-Pacific Bacillus Calmette Guerin Vaccine Revenue (2017-2028)
4.5 South America Bacillus Calmette Guerin Vaccine Revenue (2017-2028)
4.6 Middle East and Africa Bacillus Calmette Guerin Vaccine Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Bacillus Calmette Guerin Vaccine Sales in Volume by Type (2017-2028)
5.2 Global Bacillus Calmette Guerin Vaccine Revenue by Type (2017-2028)
5.3 Global Bacillus Calmette Guerin Vaccine Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Bacillus Calmette Guerin Vaccine Sales in Volume by Application (2017-2028)
6.2 Global Bacillus Calmette Guerin Vaccine Revenue by Application (2017-2028)
6.3 Global Bacillus Calmette Guerin Vaccine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Bacillus Calmette Guerin Vaccine Sales by Type (2017-2028)
7.2 North America Bacillus Calmette Guerin Vaccine Sales by Application (2017-2028)
7.3 North America Bacillus Calmette Guerin Vaccine Market Size by Country
7.3.1 North America Bacillus Calmette Guerin Vaccine Sales in Volume by Country (2017-2028)
7.3.2 North America Bacillus Calmette Guerin Vaccine Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Bacillus Calmette Guerin Vaccine Sales by Type (2017-2028)
8.2 Europe Bacillus Calmette Guerin Vaccine Sales by Application (2017-2028)
8.3 Europe Bacillus Calmette Guerin Vaccine Market Size by Country
8.3.1 Europe Bacillus Calmette Guerin Vaccine Sales in Volume by Country (2017-2028)
8.3.2 Europe Bacillus Calmette Guerin Vaccine Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Bacillus Calmette Guerin Vaccine Sales by Type (2017-2028)
9.2 Asia-Pacific Bacillus Calmette Guerin Vaccine Sales by Application (2017-2028)
9.3 Asia-Pacific Bacillus Calmette Guerin Vaccine Market Size by Region
9.3.1 Asia-Pacific Bacillus Calmette Guerin Vaccine Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Bacillus Calmette Guerin Vaccine Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Bacillus Calmette Guerin Vaccine Sales by Type (2017-2028)
10.2 South America Bacillus Calmette Guerin Vaccine Sales by Application (2017-2028)
10.3 South America Bacillus Calmette Guerin Vaccine Market Size by Country
10.3.1 South America Bacillus Calmette Guerin Vaccine Sales in Volume by Country (2017-2028)
10.3.2 South America Bacillus Calmette Guerin Vaccine Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Bacillus Calmette Guerin Vaccine Sales by Type (2017-2028)
11.2 Middle East & Africa Bacillus Calmette Guerin Vaccine Sales by Application (2017-2028)
11.3 Middle East & Africa Bacillus Calmette Guerin Vaccine Market Size by Country
11.3.1 Middle East & Africa Bacillus Calmette Guerin Vaccine Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Bacillus Calmette Guerin Vaccine Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Bacillus Calmette Guerin Vaccine and Key Manufacturers
12.2 Manufacturing Costs Percentage of Bacillus Calmette Guerin Vaccine
12.3 Bacillus Calmette Guerin Vaccine Production Process
12.4 Bacillus Calmette Guerin Vaccine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Bacillus Calmette Guerin Vaccine Typical Distributors
13.3 Bacillus Calmette Guerin Vaccine Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Bacillus Calmette Guerin Vaccine Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Bacillus Calmette Guerin Vaccine Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Bacillus Calmette Guerin Vaccine Product and Services
Table 6. Merck Bacillus Calmette Guerin Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 8. Sanofi Pasteur Major Business
Table 9. Sanofi Pasteur Bacillus Calmette Guerin Vaccine Product and Services
Table 10. Sanofi Pasteur Bacillus Calmette Guerin Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Japan BCG Lab Basic Information, Manufacturing Base and Competitors
Table 12. Japan BCG Lab Major Business
Table 13. Japan BCG Lab Bacillus Calmette Guerin Vaccine Product and Services
Table 14. Japan BCG Lab Bacillus Calmette Guerin Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. China National Biotec Basic Information, Manufacturing Base and Competitors
Table 16. China National Biotec Major Business
Table 17. China National Biotec Bacillus Calmette Guerin Vaccine Product and Services
Table 18. China National Biotec Bacillus Calmette Guerin Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. AJ Vaccines Basic Information, Manufacturing Base and Competitors
Table 20. AJ Vaccines Major Business
Table 21. AJ Vaccines Bacillus Calmette Guerin Vaccine Product and Services
Table 22. AJ Vaccines Bacillus Calmette Guerin Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 24. Serum Institute of India Major Business
Table 25. Serum Institute of India Bacillus Calmette Guerin Vaccine Product and Services
Table 26. Serum Institute of India Bacillus Calmette Guerin Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Intervax Basic Information, Manufacturing Base and Competitors
Table 28. Intervax Major Business
Table 29. Intervax Bacillus Calmette Guerin Vaccine Product and Services
Table 30. Intervax Bacillus Calmette Guerin Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. GSBPL Basic Information, Manufacturing Base and Competitors
Table 32. GSBPL Major Business
Table 33. GSBPL Bacillus Calmette Guerin Vaccine Product and Services
Table 34. GSBPL Bacillus Calmette Guerin Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Statens Serum Institute Basic Information, Manufacturing Base and Competitors
Table 36. Statens Serum Institute Major Business
Table 37. Statens Serum Institute Bacillus Calmette Guerin Vaccine Product and Services
Table 38. Statens Serum Institute Bacillus Calmette Guerin Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Biomed Lublin Basic Information, Manufacturing Base and Competitors
Table 40. Biomed Lublin Major Business
Table 41. Biomed Lublin Bacillus Calmette Guerin Vaccine Product and Services
Table 42. Biomed Lublin Bacillus Calmette Guerin Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. ANLIS Malbran Basic Information, Manufacturing Base and Competitors
Table 44. ANLIS Malbran Major Business
Table 45. ANLIS Malbran Bacillus Calmette Guerin Vaccine Product and Services
Table 46. ANLIS Malbran Bacillus Calmette Guerin Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Fundação Ataulpho de Paiva Basic Information, Manufacturing Base and Competitors
Table 48. Fundação Ataulpho de Paiva Major Business
Table 49. Fundação Ataulpho de Paiva Bacillus Calmette Guerin Vaccine Product and Services
Table 50. Fundação Ataulpho de Paiva Bacillus Calmette Guerin Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. BB-NCIPD Basic Information, Manufacturing Base and Competitors
Table 52. BB-NCIPD Major Business
Table 53. BB-NCIPD Bacillus Calmette Guerin Vaccine Product and Services
Table 54. BB-NCIPD Bacillus Calmette Guerin Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Taj Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 56. Taj Pharmaceuticals Major Business
Table 57. Taj Pharmaceuticals Bacillus Calmette Guerin Vaccine Product and Services
Table 58. Taj Pharmaceuticals Bacillus Calmette Guerin Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Bio Farma Basic Information, Manufacturing Base and Competitors
Table 60. Bio Farma Major Business
Table 61. Bio Farma Bacillus Calmette Guerin Vaccine Product and Services
Table 62. Bio Farma Bacillus Calmette Guerin Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Microgen Basic Information, Manufacturing Base and Competitors
Table 64. Microgen Major Business
Table 65. Microgen Bacillus Calmette Guerin Vaccine Product and Services
Table 66. Microgen Bacillus Calmette Guerin Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. Torlakinstitut Basic Information, Manufacturing Base and Competitors
Table 68. Torlakinstitut Major Business
Table 69. Torlakinstitut Bacillus Calmette Guerin Vaccine Product and Services
Table 70. Torlakinstitut Bacillus Calmette Guerin Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 71. Institut Pasteur de Tunis Basic Information, Manufacturing Base and Competitors
Table 72. Institut Pasteur de Tunis Major Business
Table 73. Institut Pasteur de Tunis Bacillus Calmette Guerin Vaccine Product and Services
Table 74. Institut Pasteur de Tunis Bacillus Calmette Guerin Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 75. IVAC Basic Information, Manufacturing Base and Competitors
Table 76. IVAC Major Business
Table 77. IVAC Bacillus Calmette Guerin Vaccine Product and Services
Table 78. IVAC Bacillus Calmette Guerin Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 79. Global Bacillus Calmette Guerin Vaccine Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 80. Global Bacillus Calmette Guerin Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 81. Market Position of Manufacturers in Bacillus Calmette Guerin Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 82. Global Bacillus Calmette Guerin Vaccine Production Capacity by Company, (K Units): 2020 VS 2021
Table 83. Head Office and Bacillus Calmette Guerin Vaccine Production Site of Key Manufacturer
Table 84. Bacillus Calmette Guerin Vaccine New Entrant and Capacity Expansion Plans
Table 85. Bacillus Calmette Guerin Vaccine Mergers & Acquisitions in the Past Five Years
Table 86. Global Bacillus Calmette Guerin Vaccine Sales by Region (2017-2022) & (K Units)
Table 87. Global Bacillus Calmette Guerin Vaccine Sales by Region (2023-2028) & (K Units)
Table 88. Global Bacillus Calmette Guerin Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 89. Global Bacillus Calmette Guerin Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 90. Global Bacillus Calmette Guerin Vaccine Sales by Type (2017-2022) & (K Units)
Table 91. Global Bacillus Calmette Guerin Vaccine Sales by Type (2023-2028) & (K Units)
Table 92. Global Bacillus Calmette Guerin Vaccine Revenue by Type (2017-2022) & (USD Million)
Table 93. Global Bacillus Calmette Guerin Vaccine Revenue by Type (2023-2028) & (USD Million)
Table 94. Global Bacillus Calmette Guerin Vaccine Price by Type (2017-2022) & (US$/Unit)
Table 95. Global Bacillus Calmette Guerin Vaccine Price by Type (2023-2028) & (US$/Unit)
Table 96. Global Bacillus Calmette Guerin Vaccine Sales by Application (2017-2022) & (K Units)
Table 97. Global Bacillus Calmette Guerin Vaccine Sales by Application (2023-2028) & (K Units)
Table 98. Global Bacillus Calmette Guerin Vaccine Revenue by Application (2017-2022) & (USD Million)
Table 99. Global Bacillus Calmette Guerin Vaccine Revenue by Application (2023-2028) & (USD Million)
Table 100. Global Bacillus Calmette Guerin Vaccine Price by Application (2017-2022) & (US$/Unit)
Table 101. Global Bacillus Calmette Guerin Vaccine Price by Application (2023-2028) & (US$/Unit)
Table 102. North America Bacillus Calmette Guerin Vaccine Sales by Country (2017-2022) & (K Units)
Table 103. North America Bacillus Calmette Guerin Vaccine Sales by Country (2023-2028) & (K Units)
Table 104. North America Bacillus Calmette Guerin Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 105. North America Bacillus Calmette Guerin Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 106. North America Bacillus Calmette Guerin Vaccine Sales by Type (2017-2022) & (K Units)
Table 107. North America Bacillus Calmette Guerin Vaccine Sales by Type (2023-2028) & (K Units)
Table 108. North America Bacillus Calmette Guerin Vaccine Sales by Application (2017-2022) & (K Units)
Table 109. North America Bacillus Calmette Guerin Vaccine Sales by Application (2023-2028) & (K Units)
Table 110. Europe Bacillus Calmette Guerin Vaccine Sales by Country (2017-2022) & (K Units)
Table 111. Europe Bacillus Calmette Guerin Vaccine Sales by Country (2023-2028) & (K Units)
Table 112. Europe Bacillus Calmette Guerin Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 113. Europe Bacillus Calmette Guerin Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 114. Europe Bacillus Calmette Guerin Vaccine Sales by Type (2017-2022) & (K Units)
Table 115. Europe Bacillus Calmette Guerin Vaccine Sales by Type (2023-2028) & (K Units)
Table 116. Europe Bacillus Calmette Guerin Vaccine Sales by Application (2017-2022) & (K Units)
Table 117. Europe Bacillus Calmette Guerin Vaccine Sales by Application (2023-2028) & (K Units)
Table 118. Asia-Pacific Bacillus Calmette Guerin Vaccine Sales by Region (2017-2022) & (K Units)
Table 119. Asia-Pacific Bacillus Calmette Guerin Vaccine Sales by Region (2023-2028) & (K Units)
Table 120. Asia-Pacific Bacillus Calmette Guerin Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 121. Asia-Pacific Bacillus Calmette Guerin Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 122. Asia-Pacific Bacillus Calmette Guerin Vaccine Sales by Type (2017-2022) & (K Units)
Table 123. Asia-Pacific Bacillus Calmette Guerin Vaccine Sales by Type (2023-2028) & (K Units)
Table 124. Asia-Pacific Bacillus Calmette Guerin Vaccine Sales by Application (2017-2022) & (K Units)
Table 125. Asia-Pacific Bacillus Calmette Guerin Vaccine Sales by Application (2023-2028) & (K Units)
Table 126. South America Bacillus Calmette Guerin Vaccine Sales by Country (2017-2022) & (K Units)
Table 127. South America Bacillus Calmette Guerin Vaccine Sales by Country (2023-2028) & (K Units)
Table 128. South America Bacillus Calmette Guerin Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 129. South America Bacillus Calmette Guerin Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 130. South America Bacillus Calmette Guerin Vaccine Sales by Type (2017-2022) & (K Units)
Table 131. South America Bacillus Calmette Guerin Vaccine Sales by Type (2023-2028) & (K Units)
Table 132. South America Bacillus Calmette Guerin Vaccine Sales by Application (2017-2022) & (K Units)
Table 133. South America Bacillus Calmette Guerin Vaccine Sales by Application (2023-2028) & (K Units)
Table 134. Middle East & Africa Bacillus Calmette Guerin Vaccine Sales by Region (2017-2022) & (K Units)
Table 135. Middle East & Africa Bacillus Calmette Guerin Vaccine Sales by Region (2023-2028) & (K Units)
Table 136. Middle East & Africa Bacillus Calmette Guerin Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 137. Middle East & Africa Bacillus Calmette Guerin Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 138. Middle East & Africa Bacillus Calmette Guerin Vaccine Sales by Type (2017-2022) & (K Units)
Table 139. Middle East & Africa Bacillus Calmette Guerin Vaccine Sales by Type (2023-2028) & (K Units)
Table 140. Middle East & Africa Bacillus Calmette Guerin Vaccine Sales by Application (2017-2022) & (K Units)
Table 141. Middle East & Africa Bacillus Calmette Guerin Vaccine Sales by Application (2023-2028) & (K Units)
Table 142. Bacillus Calmette Guerin Vaccine Raw Material
Table 143. Key Manufacturers of Bacillus Calmette Guerin Vaccine Raw Materials
Table 144. Direct Channel Pros & Cons
Table 145. Indirect Channel Pros & Cons
Table 146. Bacillus Calmette Guerin Vaccine Typical Distributors
Table 147. Bacillus Calmette Guerin Vaccine Typical Customers
List of Figures
Figure 1. Bacillus Calmette Guerin Vaccine Picture
Figure 2. Global Bacillus Calmette Guerin Vaccine Revenue Market Share by Type in 2021
Figure 3. Immune Type
Figure 4. Therapy Type
Figure 5. Global Bacillus Calmette Guerin Vaccine Revenue Market Share by Application in 2021
Figure 6. Hospitals
Figure 7. Clinics
Figure 8. Others
Figure 9. Global Bacillus Calmette Guerin Vaccine Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global Bacillus Calmette Guerin Vaccine Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Bacillus Calmette Guerin Vaccine Sales (2017-2028) & (K Units)
Figure 12. Global Bacillus Calmette Guerin Vaccine Price (2017-2028) & (US$/Unit)
Figure 13. Global Bacillus Calmette Guerin Vaccine Production Capacity (2017-2028) & (K Units)
Figure 14. Global Bacillus Calmette Guerin Vaccine Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Bacillus Calmette Guerin Vaccine Market Drivers
Figure 16. Bacillus Calmette Guerin Vaccine Market Restraints
Figure 17. Bacillus Calmette Guerin Vaccine Market Trends
Figure 18. Global Bacillus Calmette Guerin Vaccine Sales Market Share by Manufacturer in 2021
Figure 19. Global Bacillus Calmette Guerin Vaccine Revenue Market Share by Manufacturer in 2021
Figure 20. Bacillus Calmette Guerin Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Bacillus Calmette Guerin Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Bacillus Calmette Guerin Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Bacillus Calmette Guerin Vaccine Sales Market Share by Region (2017-2028)
Figure 24. Global Bacillus Calmette Guerin Vaccine Revenue Market Share by Region (2017-2028)
Figure 25. North America Bacillus Calmette Guerin Vaccine Revenue (2017-2028) & (USD Million)
Figure 26. Europe Bacillus Calmette Guerin Vaccine Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Bacillus Calmette Guerin Vaccine Revenue (2017-2028) & (USD Million)
Figure 28. South America Bacillus Calmette Guerin Vaccine Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Bacillus Calmette Guerin Vaccine Revenue (2017-2028) & (USD Million)
Figure 30. Global Bacillus Calmette Guerin Vaccine Sales Market Share by Type (2017-2028)
Figure 31. Global Bacillus Calmette Guerin Vaccine Revenue Market Share by Type (2017-2028)
Figure 32. Global Bacillus Calmette Guerin Vaccine Price by Type (2017-2028) & (US$/Unit)
Figure 33. Global Bacillus Calmette Guerin Vaccine Sales Market Share by Application (2017-2028)
Figure 34. Global Bacillus Calmette Guerin Vaccine Revenue Market Share by Application (2017-2028)
Figure 35. Global Bacillus Calmette Guerin Vaccine Price by Application (2017-2028) & (US$/Unit)
Figure 36. North America Bacillus Calmette Guerin Vaccine Sales Market Share by Type (2017-2028)
Figure 37. North America Bacillus Calmette Guerin Vaccine Sales Market Share by Application (2017-2028)
Figure 38. North America Bacillus Calmette Guerin Vaccine Sales Market Share by Country (2017-2028)
Figure 39. North America Bacillus Calmette Guerin Vaccine Revenue Market Share by Country (2017-2028)
Figure 40. United States Bacillus Calmette Guerin Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Bacillus Calmette Guerin Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Bacillus Calmette Guerin Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Bacillus Calmette Guerin Vaccine Sales Market Share by Type (2017-2028)
Figure 44. Europe Bacillus Calmette Guerin Vaccine Sales Market Share by Application (2017-2028)
Figure 45. Europe Bacillus Calmette Guerin Vaccine Sales Market Share by Country (2017-2028)
Figure 46. Europe Bacillus Calmette Guerin Vaccine Revenue Market Share by Country (2017-2028)
Figure 47. Germany Bacillus Calmette Guerin Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Bacillus Calmette Guerin Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Bacillus Calmette Guerin Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Bacillus Calmette Guerin Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Bacillus Calmette Guerin Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Bacillus Calmette Guerin Vaccine Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Bacillus Calmette Guerin Vaccine Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Bacillus Calmette Guerin Vaccine Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Bacillus Calmette Guerin Vaccine Revenue Market Share by Region (2017-2028)
Figure 56. China Bacillus Calmette Guerin Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Bacillus Calmette Guerin Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Bacillus Calmette Guerin Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Bacillus Calmette Guerin Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Bacillus Calmette Guerin Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Bacillus Calmette Guerin Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Bacillus Calmette Guerin Vaccine Sales Market Share by Type (2017-2028)
Figure 63. South America Bacillus Calmette Guerin Vaccine Sales Market Share by Application (2017-2028)
Figure 64. South America Bacillus Calmette Guerin Vaccine Sales Market Share by Country (2017-2028)
Figure 65. South America Bacillus Calmette Guerin Vaccine Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Bacillus Calmette Guerin Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Bacillus Calmette Guerin Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Bacillus Calmette Guerin Vaccine Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Bacillus Calmette Guerin Vaccine Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Bacillus Calmette Guerin Vaccine Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Bacillus Calmette Guerin Vaccine Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Bacillus Calmette Guerin Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Bacillus Calmette Guerin Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Bacillus Calmette Guerin Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Bacillus Calmette Guerin Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Bacillus Calmette Guerin Vaccine in 2021
Figure 77. Manufacturing Process Analysis of Bacillus Calmette Guerin Vaccine
Figure 78. Bacillus Calmette Guerin Vaccine Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のA型肝炎及びB型肝炎用混合ワクチン市場2022年：市場規模予測（～2028年）
  • 世界の肺炎球菌ワクチン多価市場2022年：市場規模予測（～2028年）
  • アジュバント使用インフルエンザワクチンのグローバル市場展望 2023年-2029年：バイアル、充填済み
  • 世界の獣医用ウイルスベクター化ワクチン市場2022年：市場規模予測（～2028年）
  • 世界のIPVワクチン市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19168 )"世界のカルメット-ゲラン桿菌ワクチン市場2022年：市場規模予測（～2028年）" (英文：Global Bacillus Calmette Guerin Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。